Correlation of rheumatoid arthritis activity indexes (Disease Activity Score 28 measured with ESR and CRP, Simplified Disease Activity Index and Clinical Disease Activity Index) and agreement of disease activity states with various cut-off points in a Northeastern Brazilian population

Revista Brasileira de Reumatologia

Volumn 55, Issue 6, 2015, Pages 477-484

  Medeiros, Marta Maria das Chagas ^a   de Oliveira, Brenda Maria Gurgel Barreto ^b   de Cerqueira, João Victor Medeiros ^c   de Souza Quixadá, Raquel Telles ^b   de Oliveira, Ídila Mont'Alverne Xavier ^b  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

^b Walter Cantídio Univ Hosp   (Brazil)

^c UNIVERSITY OF FORTALEZA   (Brazil)

Author keywords

Agreement; Correlation; DAS28; Disease activity; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; RHEUMATOID FACTOR; AMETANTRONE DIACETATE;

ADULT; ARTICLE; BRAZILIAN; CLINICAL DISEASE ACTIVITY INDEX; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DAS28; DISEASE ACTIVITY; DISEASE COURSE; DISEASE DURATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; REMISSION; RHEUMATOID ARTHRITIS; SIMPLIFIED DISEASE ACTIVITY INDEX; AGE; CASE CONTROL STUDY; CONTROLLED STUDY; CORRELATIONAL STUDY; GENDER; MIDDLE AGED; BRAZIL; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX;

ARTHRITIS, RHEUMATOID; BRAZIL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

EID: 84941030520     PISSN: 04825004     EISSN: 18094570     Source Type: Journal    
DOI: 10.1016/j.rbre.2014.12.005     Document Type: Article

References (23)

1. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatologypreliminary core set of disease activity measures forrheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.Arthritis Rheum. 1993;36:729-40.
2. Smolen JS. The work of the Eular Standing Committee on International Clinical Studies Including Therapeutic Trials. Br J Rheumatol. 1992;31:219-20.
3. Boers M, Tugwell P, Felson DT, Van Riel PL, Kirwan JR, Edmonds JP, et al. World Health Organization and International League of Associations for Rheumatology coreendpoints for symptom modifying antirheumatic drugs inrheumatoid arthritis clinical trials. J Rheumatol. 1994;41Suppl:86-9.
4. Prevoo ML, Van't Hof MA, Van Riel PL, Theunisse LA, Lubberts EW, Van Leeuwen MA, et al. Judging disease activity in clinicalpractice in rheumatoid arthritis: first step in the developmentof a disease activity score. Ann Rheum Dis. 1990;49:916-20.
5. Prevoo ML, Van't Hof MA, Kuper HH, Van Leeuwen MA, Van de Putte LB, Van Riel PL. Modified disease activity scores thatinclude twenty-eight-joint counts. Development andvalidation in a prospective longitudinal study of patients withrheumatoid arthritis. Arthritis Rheum. 1995;38:44-8.
6. Wells G, Becker JC, Teng J, Dougados M, Schiff M, Smolen J, et al. Validation of the 28-joint Disease Activity Score (DAS28)and European League Against Rheumatism response criteriabased on C-reactive protein against disease progression inpatients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis. 2009;68:954-60.
7. Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G, et al. A Simplified Disease Activity Index for rheumatoidarthritis for use in clinical practice. Rheumatology (Oxford).2003;42:244-57.
8. Aletaha D, Nell VP, Stamm T, Uffmann M, Pflugbeil S, Machold K, et al. Acute phase reactants add little to composite diseaseactivity indices for rheumatoid arthritis: validation of aclinical activity score. Arthritis Res Ther. 2005:R796-806.
9. Aletaha D, Smolen J. The Simplified Disease Activity Index(SDAI) and the Clinical Disease Activity Index (CDAI): a reviewof their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol. 2005;23 Suppl 39:S100-8.
10. Fujiwara M, Kita Y. Reexamination of the assessment criteriafor rheumatoid arthritis disease activity based on comparisonof the Disease Activity Score 28 with other simplerassessment methods. Mod Rheumatol. 2013;23:260-8.
11. Sing H, Gupta V, Ray S, Kumar H, Talapatra P, Kaur M, et al.Evaluation of disease activity in rheumatoid arthritis by Routine Assessment of Patient Index Data 3 (RAPID3) and it iscorrelation to Disease Activity Score 28 (DAS28) and Clinical Disease Activity Index (CDAI): an Indian experience. Clin Rheumatol. 2012;31:1663-9.
12. Rosa Neto NS, De Carvalho JF, Shoenfeld Y. Screening tests forinflammatory activity: applications in rheumatology. Mod Rheumatol. 2009;19:469-77.
13. Tamhane A, Redden DT, McGwin G Jr, Brown EE, Westfall AO, Reynolds RJ 4th, et al. Comparison of the disease activityscore using erythrocyte sedimentation rate and C-reactiveprotein in African Americans with rheumatoid arthritis. JRheumatol. 2013;40:1812-22.
14. Aletaha D, Ward MM, Machold KP, Nell VPK, Stamm T, Smolen JS. Remission and active disease in rheumatoid arthritis Defining criteria for disease activity states. Arthritis Rheum.2005;52:2625-36.
15. Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N.Comparison of Disease Activity Score (DAS)28-erythrocytesedimentation rate and DAS28-C-reactive protein thresholdvalues. Ann Rheum Dis. 2007;66:407-9.
16. Castrejón I, Ortiz AM, Toledano E, Castañeda S, Garcia-Vadillo A, Patino E, et al. Estimated cutoff points for the 28-jointdisease activity score based on C-reactive protein in alongitudinal register of early arthritis. J Rheumatol.2010;37:1439-43.
17. Arnett FC, Edworthy SM, Bloch DA, Mc Shane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association1987 revised criteria for the classification of rheumatoidarthritis. Arthritis Rheum. 1988;31:315-24.
18. Ferraz MB, Oliveira LM, Araujo PM, Atra E, Tugwell P.Crosscultural reability of the physical ability dimension of the Health Assessment Questionnaire. J Rheumatol.1990;17:813-7.
19. Matsui T, Kuga Y, Kaneko A, Nishino J, Eto Y, Chiba N, et al.Disease Activity Score 28 (DAS28) using C-reactive proteinunderestimates disease activity and overestimates EULARresponse criteria compared with DAS28 using erythrocytesedimentation rate in a large observational cohort ofrheumatoid arthritis patients in Japan. Ann Rheum Dis.2007;66:1221-6.
20. Bathon JM, Martin RW, Fleischmann RM, Bingham CO, Whitmore JB, Eickenhorst T. Disease activity scores using CRPversus ESR and the relationship between EULAR and ACRresponses in patients with early rheumatoid arthritis. Ann Rheum Dis. 2005;64 Suppl 3:173 [abstract].
21. Hensor EM, Emery P, Bingham SJ, Conaghan PG. Discrepanciesin categorizing rheumatoid arthritis patients by DAS-28 (ESR)and DAS28 (CRP): can they be reduced? Rheumatology.2010;49:1521-9.
22. Crowson CS, Rahman MU, Matteson EL. Which measure ofinflammation to use? A comparison of erythrocytesedimentation rate and C-reactive protein measurementsfrom randomized clinical trials of golimumab in rheumatoidarthritis. J Rheumatol. 2009;36:1606-10.
23. Rintelen B, Sautner J, Haindl PM, Andel I, Maktari A, Leeb BF.Comparison of three rheumatoid arthritis disease activityscores in clinical routine. Scand J Rheumatol. 2009;38:336-41.